29.34USD-15.81%Mkt Cap: 2.53B $P/E: —1d ago
HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid …
Industry Peers
Health Information Servicesvs Health Information Services
P/B
Pricier
1M Perf
Higher
$28.83BUSDP/E 31.5
$13.69BUSDP/E 90.6
$10.40BUSD
$7.57BUSDP/E 33.8
$6.42BUSD
$4.87BUSD
$3.94BUSDP/E 30.6
$3.24BUSDP/E 151.4
$1.89BUSDP/E 94.4
$1.53BUSD
$1.30BUSD
$1.21BUSD
$1.02BUSD
$975.39MUSDP/E 48.0
$871.07MUSDP/E Infinity
$796.11MUSDP/E 40.7
$713.43MUSDP/E 33.6
$635.66MUSDP/E 64.3
$609.65MUSD
$563.71MUSDP/E 13.3
$581.50MUSD
$501.65MUSDP/E 28.1
$516.62MUSD
$462.84MUSDP/E 26.3
$486.12MUSDP/E 55.3
$476.60MUSD
$393.13MUSDP/E 90.4
$370.16MUSD
$282.18MUSD
$227.30MUSDP/E 13.9
$213.88MUSDP/E 17.4
$199.74MUSD
$154.92MUSDP/E 30.8
$145.80MUSDP/E 39.3
$152.38MUSD
$147.05MUSD
$134.30MUSDP/E Infinity
$119.30MUSDP/E 26.6
$107.34MUSDP/E 15.9
$90.09MUSDP/E 16.3
$87.68MUSD
$63.42MUSDP/E 11.0
$62.20MUSD
$61.11MUSDP/E 22.1
$48.56MUSDP/E 46.3
$47.87MUSDP/E 57.6
$48.26MUSD
$41.23MUSD
$41.63MUSD
$23.33MUSDP/E 55.8
$23.82MUSDP/E 23.0
$21.92MUSD
$19.31MUSD
$13.45MUSD
$13.16MUSD
$10.93MUSD
$9.67MUSDP/E 14.9
$9.47MUSD
$7.09MUSD
$6.52MUSD
$5.18MUSD
$5.62MUSD
$3.80MUSDP/E Infinity
$3.67MUSDP/E 0.0
$3.46MUSD
$3.38MUSD
$2.99MUSD
$1.44MUSDP/E Infinity
$512.9KUSDP/E 0.0
$373.4KUSD
$165.6KUSD
CRY
GraniteShares YieldBOOST CRCL ETF—
EYES
Corgi Data & Surveillance ETF—P/E 30.5
—
—
—
Indicators:|
Key Statistics
Company
Market Cap2.53B $
Enterprise Value2.40B $
Revenue (TTM)191.42M $
Gross Profit135.20M $
Net Income (TTM)-116.79M $
Revenue/Share3.375 USD
Last Price29.34 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees843
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-110.99
PEG—
EV/EBITDA-35.69
EV/Revenue12.53
P/S13.22
P/B8.84
EPS (TTM)-3.09
EPS (Forward)-0.26
52W Range
20.1344% of range41.22
52W High41.22 USD
52W Low20.13 USD
Profitability
Gross Margin76.80%
Oper. Margin-41.88%
EBITDA Margin-35.10%
Profit Margin-66.35%
ROE-38.85%
ROA-32.49%
Growth
Revenue Growth41.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-54.02M $
CapEx (TTM)5.03M $
FCF Margin-25.42%
FCF Yield-1.92%
Net Debt-131.97M $
Net Debt/EBITDA1.96
Balance Sheet
Debt/Equity0.07
Current Ratio5.57
Quick Ratio5.10
Book Value/Sh3.318 USD
Cash/Share1.836 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)37.00 USD
Upside (mean)+26.1%
Target Range35.00 USD – 40.00 USD
$35.00+26.1% to mean$40.00
# Analysts6
Ownership
Shares Out.86.24M
Float66.31M
Insiders5.10%
Institutions78.97%
Short Interest
Short Ratio3.4d
Short % Float7.10%
Short % Out.4.89%
Shares Short4.21M
Short (prev mo.)3.48M
Technical
SMA 5030.68 (-4.4%)
SMA 20030.07 (-2.4%)
Beta—
S&P 52W Chg20.05%
Avg Vol (30d)1.59M
Avg Vol (10d)2.64M
Technical Indicators
RSI (14)41.4
MACD1.0754
MACD Signal1.1559
MACD Hist.-0.0806
BB Upper37.04 USD
BB Middle31.77 USD
BB Lower26.50 USD
BB Width33.18%
ATR (14)2.314 USD
Vol Ratio (20d)2.78x